Close Menu

proteomic-based diagnostics

NEW YORK (GenomeWeb News) – Drug firm Summit and the Children's National Medical Center in Washington today announced a collaboration for the development of a proteomic assay to measure biomarkers in support of Summit's candidate drug for Duchenne Muscular Dystrophy (DMD).

NEW YORK (GenomeWeb News) – The Centre of Excellence for the Prevention of Organ Failure (PROOF) and MRM Proteomics announced today that they will partner on proteomic-based diagnostic tests for patients with chronic organ diseases.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Applied Proteomics said today that it has reeled in $22.5 million in a Series B financing, has moved its corporate headquarters to San Diego, and has named Peter Klemm to be its CEO.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Biodesix today announced two partnerships to increase patient access to its VeriStrat molecular diagnostic test for non-small cell lung cancer.

The partners will co-develop mass spectrometry-based tests to predict patient response to therapies such as tamoxifen.

According to a document filed with the SEC, Biodesix has raised half of its goal of $20 million. Funds will be used to further commercialize its VeriStrat test.

Pages

Gene editing could be an issue competitive sports need to address soon, four researchers from Arizona State University write at Slate.

A genetic alteration appears to increase heart failure risk among people of African descent, according to the Washington Post.

In his look back at the past decade, BuzzFeed News' Peter Aldhous writes that direct-to-consumer genetic testing has led to "Facebook for genes."

In Nature this week: genetic "clock" that can predict the lifespans of vertebrates, new assembler called wtdbg2, and more.